Posted by Michael Wonder on 05 Sep 2019
Medicare drug price negotiation — why now . . . and how
4 September 2019 - A targeted bargaining strategy using tried and tested arbitration techniques could help Medicare balance drug innovation and affordability.
Such negotiation could lower excessively high prices, even as parts of the market where competition works well are left alone.
